Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesNet Income - MinorityNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Select Medical Holdings (SEM) Interest Expenses (2018 - 2025)

Select Medical Holdings (SEM) has disclosed Interest Expenses for 8 consecutive years, with $28.9 million as the latest value for Q4 2025.

  • On a quarterly basis, Interest Expenses changed N/A to $28.9 million in Q4 2025 year-over-year; TTM through Dec 2025 was $117.9 million, a 4.97% decrease, with the full-year FY2025 number at $117.9 million, changed N/A from a year prior.
  • Interest Expenses was $28.9 million for Q4 2025 at Select Medical Holdings, down from $30.0 million in the prior quarter.
  • In the past five years, Interest Expenses ranged from a high of $55.4 million in Q3 2024 to a low of $6.3 million in Q4 2023.
  • A 5-year average of $36.3 million and a median of $34.1 million in 2021 define the central range for Interest Expenses.
  • Peak YoY movement for Interest Expenses: surged 36.77% in 2023, then crashed 45.85% in 2025.
  • Select Medical Holdings' Interest Expenses stood at $33.9 million in 2021, then surged by 33.46% to $45.2 million in 2022, then tumbled by 86.01% to $6.3 million in 2023, then skyrocketed by 776.37% to $55.4 million in 2024, then tumbled by 47.92% to $28.9 million in 2025.
  • Per Business Quant, the three most recent readings for SEM's Interest Expenses are $28.9 million (Q4 2025), $30.0 million (Q3 2025), and $30.0 million (Q2 2025).